Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2026-03-01 @ 6:11 AM
Study NCT ID:
NCT01000961
Status:
COMPLETED
Last Update Posted:
2024-12-19
First Post:
2009-10-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RP103-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None